136 related articles for article (PubMed ID: 20124500)
1. Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furan.
Hickling KC; Hitchcock JM; Oreffo V; Mally A; Hammond TG; Evans JG; Chipman JK
Toxicol Pathol; 2010 Feb; 38(2):230-43. PubMed ID: 20124500
[TBL] [Abstract][Full Text] [Related]
2. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and Carcinogenesis Studies of Furan (CAS No. 110-00-9) in F344 Rats and B6C3F1 Mice(Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Jan; 402():1-286. PubMed ID: 12621516
[TBL] [Abstract][Full Text] [Related]
4. In vivo genotoxicity of furan in F344 rats at cancer bioassay doses.
Ding W; Petibone DM; Latendresse JR; Pearce MG; Muskhelishvili L; White GA; Chang CW; Mittelstaedt RA; Shaddock JG; McDaniel LP; Doerge DR; Morris SM; Bishop ME; Manjanatha MG; Aidoo A; Heflich RH
Toxicol Appl Pharmacol; 2012 Jun; 261(2):164-71. PubMed ID: 22507866
[TBL] [Abstract][Full Text] [Related]
5. Toxic and genotoxic effects of oral administration of furan in mouse liver.
Cordelli E; Leopardi P; Villani P; Marcon F; Macrì C; Caiola S; Siniscalchi E; Conti L; Eleuteri P; Malchiodi-Albedi F; Crebelli R
Mutagenesis; 2010 May; 25(3):305-14. PubMed ID: 20194422
[TBL] [Abstract][Full Text] [Related]
6. Gene expression and epigenetic changes by furan in rat liver.
Chen T; Williams TD; Mally A; Hamberger C; Mirbahai L; Hickling K; Chipman JK
Toxicology; 2012 Feb; 292(2-3):63-70. PubMed ID: 22079235
[TBL] [Abstract][Full Text] [Related]
7. Functional and proliferative effects of repeated low-dose oral administration of furan in rat liver.
Mally A; Graff C; Schmal O; Moro S; Hamberger C; Schauer UM; Brück J; Ozden S; Sieber M; Steger U; Schrenk D; Hard GC; Chipman JK; Dekant W
Mol Nutr Food Res; 2010 Nov; 54(11):1556-67. PubMed ID: 20540150
[TBL] [Abstract][Full Text] [Related]
8. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
9. Induction and progression of cholangiofibrosis in rat liver injured by oral administration of furan.
Hickling KC; Hitchcock JM; Chipman JK; Hammond TG; Evans JG
Toxicol Pathol; 2010 Feb; 38(2):213-29. PubMed ID: 20231548
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
Elmore LW; Sirica AE
Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and carcinogenesis studies of 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (525):1-198. PubMed ID: 17160103
[TBL] [Abstract][Full Text] [Related]
12. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,3',4,4',5-pentachlorobiphenyl (PCB 118) (Cas No. 31508-00-6) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Nov; (531):1-218. PubMed ID: 17342196
[TBL] [Abstract][Full Text] [Related]
13. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan.
Jackson AF; Williams A; Recio L; Waters MD; Lambert IB; Yauk CL
Toxicol Appl Pharmacol; 2014 Jan; 274(1):63-77. PubMed ID: 24183702
[TBL] [Abstract][Full Text] [Related]
14. Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats.
Nishimura J; Dewa Y; Muguruma M; Kuroiwa Y; Yasuno H; Shima T; Jin M; Takahashi M; Umemura T; Mitsumori K
Toxicol Sci; 2007 May; 97(1):44-54. PubMed ID: 17264098
[TBL] [Abstract][Full Text] [Related]
15. Toxicology and carcinogenesis studies of a binary mixture of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Aug; (530):1-258. PubMed ID: 17160104
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
Chan P
Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
18. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
[TBL] [Abstract][Full Text] [Related]
19. Sequential appearance of intestinal mucosal cell types in the right and caudate liver lobes of furan-treated rats.
Elmore LW; Sirica AE
Hepatology; 1992 Nov; 16(5):1220-6. PubMed ID: 1427660
[TBL] [Abstract][Full Text] [Related]
20. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder.
Kinoshita A; Wanibuchi H; Wei M; Yunoki T; Fukushima S
Toxicol Appl Pharmacol; 2007 Jun; 221(3):295-305. PubMed ID: 17481689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
